iSpeak Blog
Cannabidiol (CBD) presents a familiar, but demanding, drug-product problem: a highly lipophilic active molecule must be delivered through aqueous physiological environments, which can be reproduced. For prospective pain and inflammatory indications, formulation development therefore needs to distinguish carefully between improving the presentation of hydrophobic CBD and changing the...